| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2021 | HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE | 740 15TH ST NW | WASHINGTON | DC | 20005-1019 | DISTRICT OF COLUMBIA | USA | U01FD006676 | Consortium Led Evaluation of Integrated Human-Relevant Approaches to Identify Drug Induced Cardiovascular Liabilities | 001 | 3 | FDA | 1/8/2025 | $0 |
| | 2025 | 2021 | HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE | 740 15TH ST NW | WASHINGTON | DC | 20005-1019 | DISTRICT OF COLUMBIA | USA | U01FD006676 | Consortium Led Evaluation of Integrated Human-Relevant Approaches to Identify Drug Induced Cardiovascular Liabilities | 000 | 3 | FDA | 12/18/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $350,000 ) |
| | 2024 | 2024 | HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE | 740 15TH ST NW | WASHINGTON | DC | 20005-1019 | DISTRICT OF COLUMBIA | USA | U01FD008279 | Nitrosamines Forum to Advance Critical Translational Science (NA FACTS) | 000 | 1 | FDA | 7/31/2024 | $175,000 |
| | 2024 | 2024 | HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE | 740 15TH ST NW | WASHINGTON | DC | 20005-1019 | DISTRICT OF COLUMBIA | USA | U01FD008279 | Nitrosamines Forum to Advance Critical Translational Science (NA FACTS) | 000 | 1 | FDA | 7/31/2024 | $175,000 |
| | 2024 | 2022 | HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE | 740 15TH ST NW | WASHINGTON | DC | 20005-1019 | DISTRICT OF COLUMBIA | USA | U01FD007473 | TGx-DDI (DDT-BMQ-000008) ring trial: a cross-site validation study of an in vitro transcriptomic biomarker for genotoxicity testing | 000 | 1 | FDA | 9/24/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $347,618 ) |
| | 2023 | 2023 | HEALTH & ENVIRONMENTAL SCIENCES INSTITUTE | 740 15TH ST NW | WASHINGTON | DC | 20005-1019 | DISTRICT OF COLUMBIA | USA | U01FD006676 | Consortium Led Evaluation of Integrated Human-Relevant Approaches to Identify Drug Induced Cardiovascular Liabilities | 000 | 3 | FDA | 1/12/2023 | $173,809 |
| | 2023 | 2023 | HEALTH & ENVIRONMENTAL SCIENCES INSTITUTE | 740 15TH ST NW | WASHINGTON | DC | 20005-1019 | DISTRICT OF COLUMBIA | USA | U01FD006676 | Consortium Led Evaluation of Integrated Human-Relevant Approaches to Identify Drug Induced Cardiovascular Liabilities | 000 | 3 | FDA | 1/12/2023 | $173,809 |
| | 2023 | 2021 | HEALTH & ENVIRONMENTAL SCIENCES INSTITUTE | 740 15TH ST NW | WASHINGTON | DC | 20005-1019 | DISTRICT OF COLUMBIA | USA | U01FD006676 | Consortium Led Evaluation of Integrated Human-Relevant Approaches to Identify Drug Induced Cardiovascular Liabilities | 001 | 3 | FDA | 7/19/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $671,342 ) |
| | 2022 | 2022 | HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE | 740 15TH ST NW STE 600 | WASHINGTON | DC | 20005-1019 | DISTRICT OF COLUMBIA | USA | U01FD006676 | Consortium Led Evaluation of Integrated Human-Relevant Approaches to Identify Drug Induced Cardiovascular Liabilities | 002 | 3 | FDA | 6/22/2022 | $421,342 |
| | 2022 | 2022 | HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE | 740 15TH ST NW STE 600 | WASHINGTON | DC | 20005-1019 | DISTRICT OF COLUMBIA | USA | U01FD007473 | TGx-DDI (DDT-BMQ-000008) ring trial: a cross-site validation study of an in vitro transcriptomic biomarker for genotoxicity testing | 000 | 1 | FDA | 5/27/2022 | $250,000 |
| | 2022 | 2021 | HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE | 740 15TH ST NW STE 600 | WASHINGTON | DC | 20005-1019 | DISTRICT OF COLUMBIA | USA | U01FD006676 | Consortium Led Evaluation of Integrated Human-Relevant Approaches to Identify Drug Induced Cardiovascular Liabilities | 003 | 3 | FDA | 8/9/2022 | $0 |
| | 2022 | 2021 | HEALTH & ENVIRONMENTAL SCIENCES INSTITUTE | 740 15TH ST NW | WASHINGTON | DC | 20005-1019 | DISTRICT OF COLUMBIA | USA | U01FD006676 | Consortium Led Evaluation of Integrated Human-Relevant Approaches to Identify Drug Induced Cardiovascular Liabilities | 006 | 3 | FDA | 8/11/2022 | $0 |
| | 2022 | 2020 | HEALTH & ENVIRONMENTAL SCIENCES INSTITUTE | 740 15TH ST NW | WASHINGTON | DC | 20005-1019 | DISTRICT OF COLUMBIA | USA | U01FD006676 | Consortium Led Evaluation of Integrated Human-Relevant Approaches to Identify Drug Induced Cardiovascular Liabilities | 000 | 2 | FDA | 1/4/2022 | $0 |
| | 2022 | 2020 | HEALTH & ENVIRONMENTAL SCIENCES INSTITUTE | 740 15TH ST NW | WASHINGTON | DC | 20005-1019 | DISTRICT OF COLUMBIA | USA | U01FD006676 | Consortium Led Evaluation of Integrated Human-Relevant Approaches to Identify Drug Induced Cardiovascular Liabilities | 001 | 2 | FDA | 1/6/2022 | $0 |
| | 2022 | 2020 | HEALTH & ENVIRONMENTAL SCIENCES INSTITUTE | 740 15TH ST NW | WASHINGTON | DC | 20005-1019 | DISTRICT OF COLUMBIA | USA | U01FD006676 | Consortium Led Evaluation of Integrated Human-Relevant Approaches to Identify Drug Induced Cardiovascular Liabilities | 005 | 2 | FDA | 8/11/2022 | $0 |
| | 2022 | 2019 | HEALTH & ENVIRONMENTAL SCIENCES INSTITUTE | 740 15TH ST NW | WASHINGTON | DC | 20005-1019 | DISTRICT OF COLUMBIA | USA | U01FD006676 | Consortium Led Evaluation of Integrated Human-Relevant Approaches to Identify Drug Induced Cardiovascular Liabilities | 004 | 1 | FDA | 8/11/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $0 ) |
| | 2021 | 2021 | HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE | 740 15TH ST NW STE 600 | WASHINGTON | DC | 20005-1019 | DISTRICT OF COLUMBIA | USA | U01FD006676 | Consortium Led Evaluation of Integrated Human-Relevant Approaches to Identify Drug Induced Cardiovascular Liabilities | 001 | 3 | FDA | 8/30/2021 | $0 |
| | 2021 | 2020 | HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE | 740 15TH ST NW STE 600 | WASHINGTON | DC | 20005-1019 | DISTRICT OF COLUMBIA | USA | U01FD006676 | Consortium Led Evaluation of Integrated Human-Relevant Approaches to Identify Drug Induced Cardiovascular Liabilities | 000 | 2 | FDA | 2/2/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $498,961 ) |
| | 2020 | 2020 | HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE | 740 15TH ST NW STE 600 | WASHINGTON | DC | 20005-1019 | DISTRICT OF COLUMBIA | USA | U01FD006676 | Consortium Led Evaluation of Integrated Human-Relevant Approaches to Identify Drug Induced Cardiovascular Liabilities | 000 | 2 | FDA | 8/27/2020 | $498,961 |
|
| Issue Date FY: 2019 ( Subtotal = $500,000 ) |
| | 2019 | 2019 | HEALTH AND ENVIRONMENTAL SCIENCES INSTITUTE | 740 15TH ST NW STE 600 | WASHINGTON | DC | 20005-1019 | DISTRICT OF COLUMBIA | USA | U01FD006676 | Consortium Led Evaluation of Integrated Human-Relevant Approaches to Identify Drug Induced Cardiovascular Liabilities | 000 | 1 | FDA | 7/1/2019 | $500,000 |
|
|
